拜耳上调2025财年盈利指引

Core Insights - Bayer has raised its sales and profit guidance for 2025, now expecting group sales to be between €46 billion and €48 billion, up from the previous estimate of €45 billion to €47 billion [1] - The adjusted EBITDA is now projected to be between €9.7 billion and €10.2 billion, an increase from the prior forecast of €9.5 billion to €10 billion [1] - Core earnings per share are expected to range from €4.80 to €5.30, revised from the earlier estimate of €4.50 to €5.00 [1]